Use of a surgical specimen-collection kit to improve mediastinal lymph-node examination of resectable lung cancer

Journal of Thoracic Oncology

Volumn 7, Issue 8, 2012, Pages 1276-1282

  Osarogiagbon, Raymond U ^a,b   Miller, Laura E ^b   Ramirez, Robert A ^a,b   Wang, Christopher G ^c   O'Brien, Thomas F ^d   Yu, Xinhua ^b   Khandekar, Alim ^e   Schoettle, Glenn P ^e   Robbins, Samuel G ^f   Robbins, Edward T ^b   Gibson, Jeffrey B ^f  

^a Boston Baskin Cancer Foundation   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c Duckworth Pathology Group   (United States)

^d UNIVERSITY OF MEMPHIS   (United States)

^e Cardiovascular Center   (United States)

^f Cardiothoracic Surgery Associates   (United States)

Author keywords

Mediastinal lymph nodes; Nonsmall cell lung cancer; Quality improvement; Staging; Surgical resection

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER STAGING; CANCER SURGERY; CASE CONTROL STUDY; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; MORBIDITY; OPERATION DURATION; PATHOLOGIST; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SURGEON; TISSUE SECTION;

EID: 84863835284     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e318257fbe5     Document Type: Article

References (19)

1. Little AG, Rusch VW, Bonner JA, et al. Patterns of surgical care of lung cancer patients. Ann Thorac Surg 2005;80:2051-205 6; discussion 2056.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225-249.
3. Goldstraw P, Crowley J, Chansky K, et al.; International Association for the Study of Lung Cancer International Staging Committee; Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007;2:706-714.
4. Rusch VW, Crowley J, Giroux DJ, et al.; International Staging Committee; Cancer Research and Biostatistics; Observers to the Committee; Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 2007;2:603-612.
5. The International Adjuvant Lung Cancer Trial Collaborative Group. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004;350:351-360.
6. Winton T, Livingston R, Johnson D, et al.; National Cancer Institute of Canada Clinical Trials Group; National Cancer Institute of the United States Intergroup JBR.10 Trial Investigators. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 2005;352:2589-2597.
7. Pignon JP, Tribodet H, Scagliotti GV, et al.; LACE Collaborative Group. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol 2008;26:3552-3559.
8. Lally BE, Zelterman D, Colasanto JM, Haffty BG, Detterbeck FC, Wilson LD. Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database. J Clin Oncol 2006;24:2998-3006.
9. Rami-Porta R, Wittekind C, Goldstraw P; International Association for the Study of Lung Cancer (IASLC) Staging Committee. Complete resection in lung cancer surgery: proposed definition. Lung Cancer 2005;49:25-33.
10. Lardinois D, De Leyn P, Van Schil P, et al. ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer. Eur J Cardiothorac Surg 2006;30:787-792.
11. Wu Y, Huang ZF, Wang SY, Yang XN, Ou W. A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer. Lung Cancer 2002;36:1-6.
12. Gajra A, Newman N, Gamble GP, Kohman LJ, Graziano SL. Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer. J Clin Oncol 2003;21:1029-1034.
13. Varlotto JM, Recht A, Nikolov M, Flickinger JC, Decamp MM. Extent of lymphadenectomy and outcome for patients with stage I nonsmall cell lung cancer. Cancer 2009;115:851-858.
14. Allen JW, Farooq A, OBrien TF, Osarogiagbon RU. Quality of surgical resection for nonsmall cell lung cancer in a US metropolitan area. Cancer 2011;117:134-142.
15. Osarogiagbon RU, Allen JW, Farooq A, Wu JT. Objective review of mediastinal lymph node examination in a lung cancer resection cohort. J Thorac Oncol 2011;7:390-396.
16. RADIANT. Available at http://www.clinicaltrials.gov/ct2/show/NCT00373425? term=RADIANTrank=4. Accessed December 15, 2011.
17. E1505 Trial Overview. Available at http://www.ecog.dfci.harvard.edu/ general/E1505-trial-overview.pdf. Accessed December 15, 2011.
18. Makary MA, Epstein J, Pronovost PJ, Millman EA, Hartmann EC, Freischlag JA. Surgical specimen identification errors: a new measure of quality in surgical care. Surgery 2007;141:450-455.
19. Darling GE, Allen MS, Decker PA, et al. Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial. J Thorac Cardiovasc Surg 2011;141:662-670.